24.10.2019 22:30:00

The Medicines Company to Announce Third Quarter 2019 Financial Results on October 30

The Medicines Company (NASDAQ: MDCO) will host a conference call and audio webcast on Wednesday, October 30, 2019 at 8:30 a.m. EDT to discuss its third quarter 2019 financial results and operational developments.

The conference call may be accessed by telephone as follows:

U.S./Canada:

(877) 407-0312

International:

(201) 389-0899

Conference ID:

13696004

A live audio webcast of the conference call may be accessed in the Investors section of The Medicines Company website.

A taped replay of the conference call will be available after the call concludes, and may be accessed by telephone as follows:

U.S./Canada:

(877) 660-6853

International:

(201) 612-7415

Conference ID:

13696004

An archived webcast will be also be available after the call concludes.

About The Medicines Company

The Medicines Company (NASDAQ: MDCO) is a biopharmaceutical company with a singular, relentless focus on addressing the greatest global healthcare challenge and burden today – cardiovascular disease. Our purpose is to halt the deadly progression of atherosclerosis and the cardiovascular risk created by high levels of LDL cholesterol. The Company is headquartered in Parsippany, New Jersey. For more information, please visit www.themedicinescompany.com and follow us on Twitter @MDCONews and LinkedIn.

Analysen zu Medicines Co.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!